Literature DB >> 2022635

Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets.

J P Scott1, R R Montgomery, G S Retzinger.   

Abstract

Ristocetin in aqueous solution dimerizes with an equilibrium dissociation constant of 5.0 x 10(-4) M, i.e. approximately 1.1 mg ml-1 (Waltho, J.P., and Williams, D. H. (1989) J. Am. Chem. Soc. 111, 2475-2480). At concentrations of about 1.0 mg ml-1 ristocetin flocculates many proteins, lyses platelets and, in the presence of von Willebrand factor, agglutinates both fresh and formalin-fixed platelets. Because ristocetin exists as both monomeric and dimeric species, we sought to determine which of these forms flocculates proteins and agglutinates platelets. We found that: 1) the initial rate of flocculation of certain proteins, 2) the initial rate of agglutination of formalin-fixed platelets, and 3) the binding of ristocetin to formalin-fixed platelets are higher order solely with respect to the concentration of ristocetin dimers. As to the operative mechanism, it appears that bifunctional dimers cross-link proteins that possess multiple copies of a common recognition site. Preliminary evidence indicates that a recognition site is a beta-turn of the form X-P-G-X'.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022635

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Role of von Willebrand factor in the haemostasis.

Authors:  Flora Peyvandi; Isabella Garagiola; Luciano Baronciani
Journal:  Blood Transfus       Date:  2011-05       Impact factor: 3.443

Review 2.  von Willebrand factor.

Authors:  Z M Ruggeri
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  Vwf K1362A resulted in failure of protein synthesis in mice.

Authors:  Naomi Sanda; Nobuaki Suzuki; Atsuo Suzuki; Takeshi Kanematsu; Mayuko Kishimoto; Hidetoshi Hasuwa; Akira Takagi; Tetsuhito Kojima; Tadashi Matsushita; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2018-02-01       Impact factor: 2.490

4.  von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure.

Authors:  L Holmberg; J A Dent; R Schneppenheim; U Budde; J Ware; Z M Ruggeri
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

5.  Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.

Authors:  M Murata; S R Russell; Z M Ruggeri; J Ware
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.

Authors:  Kenji Nishio; Patricia J Anderson; X Long Zheng; J Evan Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

7.  Platelet aggregation induced by serotype polysaccharides from Streptococcus mutans.

Authors:  Jean-San Chia; Ya-Lin Lin; Huei-Ting Lien; Jen-Yang Chen
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Point mutation in a leucine-rich repeat of platelet glycoprotein Ib alpha resulting in the Bernard-Soulier syndrome.

Authors:  J Ware; S R Russell; P Marchese; M Murata; M Mazzucato; L De Marco; Z M Ruggeri
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 9.  Glycans and the platelet life cycle.

Authors:  Renhao Li; Karin M Hoffmeister; Hervé Falet
Journal:  Platelets       Date:  2016-05-02       Impact factor: 3.862

10.  Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.

Authors:  V H Flood; K D Friedman; J C Gill; P A Morateck; J S Wren; J P Scott; R R Montgomery
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.